|

Alemtuzumab Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Campath, Campath-1H

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Paul Szabolcs2
  • Biogen1

Indications

  • Systemic Juvenile Idiopathic Arthritis (sJIA)1
  • Inflammatory Conditions1
  • Hereditary Anemias1
  • Inherited Metabolic Disorders (IMD)1
  • Congenital Bone Marrow Failure Syndromes1

Pittsburgh, Pennsylvania2 trials

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

UPMC Presbyterian

Phase 1/2
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

UPMC Children's Hospital of Pittsburgh

Phase 2

Eden Prairie, Minnesota1 trial

A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

OptumInsight

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.